1 April 2006   
News
Executive Vice President's Message
Creating a Culture of Patient Safety Through Risk Management
Volunteer Focus
CLSI to Fund Platelet Function Testing Project Using Donor Restricted Funds
Press Releases
Standards Status
Vote and Deadlines
Recently Approved Documents
Call for Nominations
Events and Exhibits
Upcoming Events
Upcoming Presentations
CLSI Meetings Calendar
Participate in CLSI
Volunteer
New and Sustaining Members
Update Your Subscription
 
CLSI Home Page
Search Past Issues
Update Your Contact Information
Print this article Print all articles
 
 
 
Winner of the Silver Award for Patient Education in the WWW Health Awards Program
Standards Status

Vote and Deadlines
Statistical Quality Control for Quantitative Measurement Procedures (C24-A3); Leukocyte Differential Count (Proportional) and Evaluation of Instrumental Methods (H20-A2); Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells (H43-A2); Point-of-Care Connectivity (POCT1-A2)

CLSI submits the following for vote as candidate-for-advancement consensus documents.  The documents and ballots are available to delegates and alternates of Active and Associate Active member organizations through CLSI Forums.  

C24-A3Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions; Approved Guideline—Third Edition
This guideline provides definitions of analytical intervals; planning of quality control procedures; and guidance for quality control applications. The deadline for the completed ballot for C24-A3 to be received at the CLSI offices is 17 April 2006.

H20-A2Reference Leukocyte Differential Count (Proportional) and Evaluation of Instrumental Methods; Approved Standard—Second Edition
A reference method for the evaluation of automated differential counters, based on the visual differential count. The deadline for the completed ballot for H20-A2 to be received at the CLSI offices is 17 April 2006.

H43-A2Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline—Second Edition
This document provides performance guidelines for the immunophenotypic analysis of neoplastic hematolymphoid cells using immunofluorescence-based flow cytometry; for sample and instrument quality control; and precautions for acquisition of data from neoplastic hematolymphoid cells. The deadline for the completed ballot for H43-A2 to be received at the CLSI offices is 15 May 2006.

Second Notice

POCT1-A2Point-of-Care Connectivity; Approved Standard—Second Edition
This document provides the framework for engineers to design devices, work stations, and interfaces that allow multiple types and brands of point-of-care devices to communicate bidirectionally with access points, data managers, and laboratory information systems from a variety of vendors. A CLSI, IFCC, and CIC joint publication. The deadline for the completed ballot for POCT1-A2 to be received at the CLSI offices is 1 May 2006.


Under our Administrative Procedures, a CLSI document approved by the area committee at the first level of the consensus process is submitted to delegates as a “candidate-for-advancement” consensus document. This begins the voting and approval period by the delegates.

As a delegate, your vote is to affirm (or reject) the document for advancement as a CLSI document. Please send your completed ballot to the CLSI offices by the above deadline.

In the consensus process, comments are invited at each publication stage. In each edition, the responsible committee includes a summary of comments on the prior edition and its responses to them. Any comments received on a candidate-for-advancement consensus document as a result of delegate voting and consensus review will be addressed by the committee during the document’s advancement.

Find out more about Active and Associate Active membership.

  [ return to top ]

For more information or to contact us directly, please visit www.clsi.org
©2006 Clinical and Laboratory Standards Institute